mhmmm, amboss contradicts slightly here - says mild disease = glucocorticoids PLUS methotrexate (can use cyclophos or rituximab if not benefit from MTX) - says moderate to severe disease = glucocorticoids PLUS (cyclo or ritux) which would agree with card and FA 2022 - thinking maybe need specifier in text or reformatting that includes mild vs mod/severe treatments
nevermind UTD seems to not like MTX for initial therapy so amboss may need updated actually - amboss article hasnt been updated since may 2022 and UTD was OCT 2022
not sure if we want to add a cloze 2 here tho or just make it all cloze 1